← Evidence map

ArticleDiscover oncology2026

Cost effectiveness analysis of PEG-rhG-CSF versus rhG-CSF for primary prophylaxis of chemotherapy induced neutropenia in Chinese patients with non-Hodgkin lymphoma using real world data.

Yiwen Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Cost effectiveness analysis of PEG-rhG-CSF versus rhG-CSF for primary prophylaxis of chemotherapy induced neutropenia in Chinese patients with non-Hodgkin lymphoma using real world data. | OpenQuestion